FDA
-
-
-
-
-
-
-
PTC Therapeutics Provides Corporate Update and Reports First Quarter 2026 Financial Results
-
-
-
-
-
-
-
PTC Therapeutics Provides Update at J.P. Morgan Annual Healthcare Conference
-
-
-
-
-
-
-
Leerink Partners Reiterates Market Perform Rating on PTC Therapeutics (PTCT)
-
-
-
-
-
-
-
PTC Therapeutics (PTCT) PT Raised to $120 at Cantor Fitzgerald
-
-
-
-
-
-
-
PTC Therapeutics (PTCT) PT Lowered to $42 at Barclays
-
-
-
-
-
-
-
PTC Therapeutics Provides Corporate Update and Reports Fourth Quarter and Full Year 2024 Financial Results
-
-
-
-
-
-
-
TD Cowen: '10 Potential "Thome Run" Catalysts to Watch in 2025'
-
329,914 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

